PMID: 9645454Jun 30, 1998Paper

Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion

Journal of Cancer Research and Clinical Oncology
G SawickiA Janowska-Wieczorek

Abstract

The enhanced expression of matrix metalloproteinases (MMP), especially gelatinases MMP-2 and MMP-9, has been associated with the invasive behavior of tumor cells. Previously we reported that primary acute myelogenous leukemia blasts and human leukemic cultured KG-1 cells but not HEL cells penetrate a reconstituted basement membrane (Matrigel) in an invasion assay. In this study, we investigated the role of MMP-2 and MMP-9 in in vitro invasion by leukemic cells. We found that both recombinant human tissue inhibitor of metalloproteinase-2 (rhTIMP-2) and anti-MMP-2 antibody inhibit the invasiveness of KG-1 cells in the Matrigel assay (by 76% and 51% respectively), while anti-MMP-9 antibody does not, indicating that MMP-2 but not MMP-9 in involved in the invasive process. KG-1 cells were found to secrete constitutively the latent (but not the activated) forms of both MMP-2 and MMP-9 and, after stimulation with the phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA), higher levels of these pro-MMP. TPA stimulation, however, did not increase the in vitro invasiveness of these cells. Analysis by Western blot and flow cytometry revealed the presence of the activated form of MMP-2 (64 kDa) on the surface of KG-1 cells and primary A...Continue Reading

Citations

May 26, 2004·Critical Reviews in Oncology/hematology·G KleinE S J M de Bont
May 19, 2009·International Journal of Cancer. Journal International Du Cancer·Ju Han SongTae Sung Kim
Oct 15, 2013·Journal of Cellular Physiology·Wen-Hsin LiuLong-Sen Chang
Jan 1, 1999·Hematology·A Janowska-WieczorekL A Marquez
Dec 18, 2018·Journal of Pediatric Hematology/oncology·Ali Amin AsnafiSaeid Shahrabi
Apr 17, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Meltem SariahmetogluRichard Schulz
Aug 6, 2020·Diagnostics·Aleksandra KaczorowskaElżbieta Adamkiewicz-Drożyńska
May 7, 2021·Nature Reviews. Cancer·Andrew E WhiteleyDorothy A Sipkins
Jun 23, 2021·European Journal of Medicinal Chemistry·Sanjib DasTarun Jha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.